MedTrace Logo

Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

NCT04409717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2020-06-01

No results posted yet for this study

Summary

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Conditions

  • Abdominal Aortic Aneurysm

Interventions

PROCEDURE

Type II endoleak treatment

Type II endoleak endovascular treatment

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Principal Investigators

  • Eric STEINMETZ, MD · Cardiovascular and Thoracic Surgery Unit - Dijon Univeristy Hospital

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-05-26
Completion
2020-05-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04409717 on ClinicalTrials.gov